🧵 Most recently, the @nobelprize.org winning scientist Sir Paul Nurse presided over poor research culture at the @crick.ac.uk. When challenged about it he denied having any knowledge of whistleblowing issues around bullying, discrimination, harassment & victimisation
www.linkedin.com/pulse/ula-sc...

🧵Can we bring more cures for brain diseases by 2030? Two Steps Forward, One Step Back: The Long Road to Success in Central Nervous System (CNS); Trends in Neuroscience Drug Discovery and Development; Pharma Ins & Outs Neurology provide some excellent insights. See www.linkedin.com/posts/brainc...

2025–Many high-flying AI companies struggled while a few techbios turbocharged with millions. lnkd.in/dVaGzWw3 outlines partnerships between AI biotech startups & pharma. Isn’t it interesting that @insitro.bsky.social’s CEO is the only female among 8 male techbio leaders making headlines this year?

Congratulations to science sleuth @sholtodavid.bsky.social for his successful whistleblowing on poor research integrity matters at @danafarber.bsky.social. The scientific misconduct whistleblower wins $2.63 million from major cancer institute in $15M settlement. See
www.linkedin.com/posts/krzysz...

#ResearchCulture Chronic silencing is a critical barrier to breaking the cycle of bullying in academia and industry by Alison Vogelaar and Morteza Mahmoudi. See www.linkedin.com/posts/krzysz... for further Academic Parity papers

🧵 Elon Musk and the developing The Royal Society saga highlights:
1) An open letter to the President of the Royal Society – time to stand up for your values by Steve Curry
2) Dorothy Bishop @deevybee.bsky.social's blog on why she resigned from the Royal Society
www.linkedin.com/posts/krzysz...